Published in J Pharm Biomed Anal on November 19, 2004
Microbiological assay for the determination of meropenem in pharmaceutical dosage form. J Pharm Biomed Anal (2004) 1.11
Comparison of microbiological and UV-spectrophotometric assays for determination of voriconazole in tablets. J AOAC Int (2006) 0.91
Structural elucidation of rabeprazole sodium photodegradation products. J Pharm Biomed Anal (2007) 0.89
Biological assay and liquid chromatographic method for analysis of moxifloxacin in tablets. J AOAC Int (2005) 0.89
Comparison of capillary electrophoresis and reversed-phase liquid chromatography methodologies for determination of diazepam in pharmaceutical tablets. J Pharm Biomed Anal (2005) 0.88
Isolation and structure elucidation of photodegradation products of fexofenadine. J Pharm Biomed Anal (2007) 0.88
Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample. J Pharm Biomed Anal (2006) 0.87
Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form. J Pharm Biomed Anal (2003) 0.85
Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles. Eur J Pharm Biopharm (2007) 0.84
Characterisation and stability evaluation of bixin nanocapsules. Food Chem (2013) 0.83
Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules. J AOAC Int (2004) 0.82
First-derivative spectrophotometry in the analysis of rosiglitazone in coated tablets. J AOAC Int (2006) 0.81
Stability indicating LC method to determination of sodium montelukast in pharmaceutical dosage form and its photodegradation kinetics. J Chromatogr Sci (2011) 0.81
New high-performance liquid chromatographic method for determination of clopidogrel in coated tablets. J AOAC Int (2008) 0.81
Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets. J Pharm Pharm Sci (2005) 0.81
Stability of carotenoids, total phenolics and in vitro antioxidant capacity in the thermal processing of orange-fleshed sweet potato (Ipomoea batatas Lam.) cultivars grown in Brazil. Plant Foods Hum Nutr (2012) 0.81
New liquid chromatographic method for determination of rabeprazole sodium in coated tablets. J AOAC Int (2004) 0.81
Capillary electrophoresis method for fexofenadine hydrochloride in capsules. J AOAC Int (2005) 0.81
Development and validation of a dissolution test for rabeprazole sodium in coated tablets. J Pharm Biomed Anal (2006) 0.80
Comparison between capillary electrophoresis and liquid chromatography for the determination of diclofenac sodium in a pharmaceutical tablet. J AOAC Int (2002) 0.78
Biological safety studies of gemifloxacin mesylate and related substances. Photochem Photobiol Sci (2013) 0.76
Micellar electrokinetic chromatographic method for mianserin hydrochloride and analysis of degradation products by mass spectrometry. Chem Pharm Bull (Tokyo) (2012) 0.75
Stress degradation studies and kinetic determinations of duloxetine enteric-coated pellets by HPLC. J AOAC Int (2011) 0.75
Fesoterodine stress degradation behavior by liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry. Talanta (2011) 0.75
LC/MS/MS study for identification of entacapone degradation product obtained by photodegradation kinetics. J AOAC Int (2011) 0.75
Gemifloxacin mesylate (GFM) stability evaluation applying a validated bioassay method and in vitro cytotoxic study. Talanta (2010) 0.75
Stability-indicating RP-LC method for the determination of vildagliptin and mass spectrometry detection for a main degradation product. J Chromatogr Sci (2012) 0.75
Highly selective colorimetric method to determine gemifloxacin mesylate in the presence of a synthetic impurity. J AOAC Int (2014) 0.75
LC determination of entacapone in tablets: in vitro dissolution studies. J Chromatogr Sci (2010) 0.75
Validation of a capillary electrophoresis method for analysis of rabeprazole sodium in a pharmaceutical dosage form. J AOAC Int (2005) 0.75
Determination of fesoterodine in pharmaceutical formulations by using liquid chromatography-tandem mass spectrometry. Eur J Mass Spectrom (Chichester, Eng) (2010) 0.75
Development and validation of column high-performance liquid chromatographic and ultraviolet spectrophotometric methods for citalopram in tablets. J AOAC Int (2008) 0.75
Second-Order Derivative UV Spectrophotometric Method for the Determination of Fesoterodine and Comparison with LC, CE and LC-MS/MS in Commercial Extended-Release Tablets. Acta Chim Slov (2012) 0.75
Simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC method. J Sep Sci (2011) 0.75
Identification, characterization and cytotoxicity in vitro assay of nitazoxanide major degradation product. Talanta (2012) 0.75
Determination of fesoterodine in a pharmaceutical preparation by a stability-indicating capillary zone electrophoresis method. J AOAC Int (2014) 0.75
Development and validation of liquid chromatographic and ultraviolet derivative spectrophotometric methods for determination of epinastine hydrochloride in coated tablets. J AOAC Int (2007) 0.75
Gemifloxacin mesylate (GFM): dissolution test based on in vivo data. Drug Dev Ind Pharm (2014) 0.75
Characterization and antioxidant potential of Brazilian fruits from the Myrtaceae family. J Agric Food Chem (2012) 0.75